Paracetamol;Paracetamol

DOLOR

Volumn 19, Issue 1, 2004, Pages 5-15

  Farre M ^a,b   Abanades, S ^a   Alvarez Y ^a   Barral, D ^a   Roset, P N ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Acetaminophen; Paracetamol; Pharmacokinetics; Pharmacology

Indexed keywords

CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450 2E1; DICLOFENAC; DIPYRONE; DOMPERIDONE; IBUPROFEN; INDOMETACIN; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OPIATE; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; RIFAMPICIN; RITONAVIR;

CHRONIC PAIN; DOSE RESPONSE; DRUG ACTIVITY; DRUG COST; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; FEVER; GLUCURONIDATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER TOXICITY; NEOPLASM; PAIN; PREGNANCY; REVIEW; RHEUMATIC DISEASE; STOMACH LESION; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION;

EID: 33749470630     PISSN: 02140659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. ACR - American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheumat 2000;43:1905-15.
2. AGP - American Geriatric Society Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 Suppl):205-24.
3. Baños JE, Casanovas L. Paracetamol 101 años después. Rev Soc Esp Dolor 1994;Suppl I:117-8.
4. Baños JE, Farré M. Bases terapéuticas del dolor agudo. En: Rodés J, Carné X, Trilla A (eds). Manual de Terapéutica Médica. Barcelona: Massen 2002:39-56.
5. Barden J, Edwards JE, Moore RA, Collins SL, McQuay HJ. Single dose paracetamol (acetaminophen) for postoperative pain. The Cochrane Library. Oxford: Update Software 2002.
6. Berde CB, Sethna NF. Analgesics for the tratment of pain in children. N Engl J Med 2002;347:1094-103.
7. CPS - Canadian Paediatric Society. Acetaminophen and ibuprofen in the management of fever and mild to moderate pain in children. Position Statements, Practice Point: Prepared by the Drug Therapy and Hazardous Substances Committee. Reaffirmed January 2002. Reference No. DT98-01 (Formerly DTP98-01). Former versions published in: Paediatrics & Child Health 1998;3(4). Consultado en: http://www.cps.ca/english/statements/DT/dt98-01.htm, 04/06/03.
8. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-31.
9. Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med 2002;162:2204-8.
10. Dargan PI, Jones AL. Management of paracetamol poisoning. Trend Pharmacol Sci 2003;24:154-7.
11. De Miguel E, Domínguez-Gilb A, Morales-Olivasc FJ, Varela C, Riesgo Y. Estudio de la utilización de medicamentos en la artrosis. Rev Esp Reumatol 2003;30:12-9.
12. Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 2002; 40: 604-8.
13. Dollery C (ed). Therapeutic drugs. Vol 2. Edimburgo: Churchill Livingstone 1991.
14. Farré M, Hernández-López C, Roset PN. Farmacología del paracetamol: dosis óptima. Dolor 2001a;16(Suppl I):5-11.
15. Farré M, Roset PN, Pascual JA, et al. Estudio de la velocidad de absorción y de la biodisponibilidad de Gelocatil comprimidos 650 mg. Dolor 2001b;16:27-32.
16. Farré M, Roset PN, Pascual JA, et al. Estudio de la velocidad de absorción y de la biodisponibilidad de paracetamol solución. Dolor 2002;17:15-8.
17. Farré M, Roset PN, Pascual JA, et al. Estudio de la biodisponibilidad comparativa de una asociación de paracetamol y codeína frente a un preparado de referencia. Dolor 1999;14:279-86.
18. a ed. Barcelona: Masson SA 2003.
19. a ed. Amsterdam: Elsevier Science 2000.
20. Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003;30:2226-33.
21. García-Rodríguez LA, Hernández-Díaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570-6.
22. Granados-Soto V, Castaneda-Hernández G. A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine. J Pharmacol Toxicol Methods 1999;42:67-72.
23. Hahn TW, Mogensen T, Lund C, et al. Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain. Acta Anesthesiol Scand 2003;47:138-45.
24. Henry D, Lim LL, García-Rodríguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-656.
25. Hernández-Díaz S, García-Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093-9.
26. Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth 2002;88:199-214.
27. Ibáñez L, Pérez E, Vidal X, Laporte JR, Grup d'Estudi Multicèntric d'Hepatotoxicitat Aguda de Barcelona (GEM-HAB). Prospective surveillance of acute serious liver disease unrelated to infectious, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 2002;37:592-600.
28. Kim RB (ed). The Medical Letter. Compendio de interacciones adversas de medicamentos. Barcelona: Prous Science 2002.
29. Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001;161:2247-52.
30. Kwan D, Bartle WR, Walker SE. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 1999;39:68-75.
31. Lanas A, Serrano P, Bajador E, Fuentes J, Sainz R. Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 2003;15:173-8.
32. Le Parc JM, Van Ganse E, Moore N, Wall R, Schneid H, Verriere F. Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: Results in 4291 patients. Clin Rheumatol 2002;21:28-31.
33. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999;104:e39.
34. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002;54:320-6.
35. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368-73.
36. Lipworth L, Friis S, Mellemkjaer L, et al. A population-based cohort study of mortality among adults prescribed paracetamol in Denmark. J Clin Epidemiol 2003;56:796-801.
37. Litauen C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children. Paediatr Drugs 2001;3:817-58.
38. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc 2002;133:861-71.
39. Moller PL, Norholt SE, Ganry HE, et al. Time to onset of analgesia and analgesic efficacy of effervescent acetaminophen 1000 mg compared to tablets acetaminophen 1000 mg in postoperative dental pain: a single-dose, double-blind, randomized, placebo-controlled study. J Clin Pharmacol 2000;40:370-8.
40. Moore A, Collins S, Carroll D, McQuay H. Paracetamol with and without codeine in acute pain: a quantitative systematic review. Pain 1997;70:193-201.
41. Moore A, Collins S, Carroll D, McQuay H, Edwards J. Dosis únicas de paracetamol (acetaminofén), con y sin codeína, para el dolor postquirúrgico. En: La Cochrane Library plus en español. Oxford: Update Software 2000. Consultado en: http://www.update-software. com/clibplus/clibplus.htm, 29/10/04.
42. Moore N, Van Ganse E, Le Parc JM, et al. The PAIN Study: Paracetamol, Aspirin and Ibuprofen New tolerability study. Clin Drug Invest 1999;18:89-98.
43. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001;322:266-70.
44. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
45. Peiró AM, Roset PN, Farré M. Paracetamol. Interacciones. Pacientes polimedicados. Dolor 2001;16(Suppl 1):20-4.
46. Prescott LF. Acetaminophen (Paracetamol). A critical bibliographic review. Londres: Taylor & Francis 1996.
47. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000;49:291-301.
48. Rampal P, Moore N, Van Ganse E, et al. Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses. J Int Med Res 2002;30:301-8.
49. Roca-Vinardell A, Ortega-Álvaro A, Gibert-Rahola J, Micó JA. The role of 5-HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen. Anesthesiol 2003;98:741-7.
50. Routledge P, Vale JA, Bateman DN, et al. Paracetamol (acetaminophen) poisoning. BMJ 1998;317:1609-10.
51. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002;40:3-20.
52. Ruoff G. Management of pain in patients with multiple health problems: a guide for the practicing physician. Am J Med 1998;105(1B):53-60.
53. Sanaka M, Kuyama Y, Yamanaka M. Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids. J Gastroenterol 1998;33:785-91.
54. Schwab JM, Schluesener HJ, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet 2003;361:981-2.
55. Skoglund LA, Pettersen N. Effects of acetaminophen after bilateral oral surgery: double dose twice daily versus standard dose four times daily. Pharmacotherapy 1991;11:370-5.
56. Smith LA, Moore RA, McQuay HJ, Gavaghan D. Using evidence from different sources: an example using paracetamol 1000 mg plus codeine 60 mg. BMC Medical Research Methodology 2001;1:1. Consultado en: http:/www.biomedcentral.com/1471- 2288/1/1,10/07/04.
57. a ed. Barcelona: Pharma Editores 2003.
58. Tannenbaum H, Peloso PMJ, Russell AS, Marlow B. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 2000;7(Suppl A):4-16.
59. Temple AR. Review of comparative antipyretic activity in children. Am J Med 1983;75(Suppl 5A):38-46.
60. Vallano A. Manejo racional de los analgésicos-antipiréticos (AA) y antiinfamatorios no esteroideos (AINE). Dolor 2001;16(Suppl I):12-9.
61. Van den Bemt PM, Geven LM, Kuitert NA, Risselada A, Brouwers JR. The potential interaction between oral anticoagulants and acetaminophen in everyday practice. Pharm World Sci 2002;24:201-4.
62. Warner TD, Mitchell JA. Cyclooxigenase-3 (COX-3): Filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA 2002;99:13371-3.
63. Whitcomb DC, Black GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-50.
64. Wong A, Sibbald A, Ferrera F, et al., Fever Pediatric Study Group. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified double-blind study. Clin Pediatr (Phila) 2001;40:313-24.
65. Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002;298:422-4.